amisulpride
Amisulpride is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Reference standards of Amisulpride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Amisulpride (IPRS/69/13)-from IPC
[catalogue_number] => PA IPIPRS 69 13
[category_ids] => ,151,
[chemical_name] =>
[weight] => NA
[form] =>
[cas] => NA
[pslug] => amisulpride-iprs-69-13-paipiprs6913
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Amisulpride (IPRS/69/13)-from IPC
stdClass Object
(
[pname] => Amisulpride (IPRS/73/19) - from IPC
[catalogue_number] => PA IPRS 73 19
[category_ids] => ,151,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => amisulpride-iprs-73-19-paiprs7319
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Amisulpride (IPRS/73/19) - from IPC
